Johnson & Johnson announces its dual-energy ablation catheter---THERMOCOOL SMARTTOUCH SFReceived CE approval for marketing.The THERMOCOOL SMARTTOUCH SF Ablation Catheter with dual energy is a porous-tip saline-irrigated and contact-force sensing ablation catheter, powered by the TRUPULSE generator and fully integrated with CARTO 3.Dual-EnergyTHERMOCOOL SMARTTOUCH SFAblationCatheters and the most commonly used on the marketThe RF THERMOCOOL SMARTTOUCH SF ablation catheter is designed on the same platform,Dual-EnergyTHERMOCOOL SMARTTOUCH SFAblationDoctors will have a seamless transition and easily master the use of the catheter after its market launch.Dual-EnergyTHERMOCOOL SMARTTOUCH SFAblationCatheter use.
"As the number of patients with atrial fibrillation grows globally, physicians are looking for integrated and flexible tools to help provide safe, effective, and efficient cardiac ablation procedures.RF and PFA"Energy has significant advantages in clinical practice. Using the dual-energy THERMOCOOL SMARTTOUCH SF ablation catheter allows for easy switching between RF and PF energy, enabling flexible customization of treatment based on the patient’s anatomy and clinical needs. This empowers physicians to perform more targeted ablation procedures, thereby improving patient outcomes."---Tom De Potter OLV HospitalExecutive Assessment
"Through our collaboration with electrophysiologists around the world, we understand that every atrial fibrillation procedure is unique. The ability to use both radiofrequency and PFA energy through a single device will allow physicians to personalize each procedure based on the patient’s anatomy and clinical needs, while providing the point-by-point workflow favored by many of our customers. The Dual-Energy THERMOCOOL SMARTTOUCH SF Ablation Catheter offers the benefits of two energy modalities in one familiar device. We are excited to introduce this innovation, enabling physicians to deliver safe and effective procedures for patients in Europe affected by atrial fibrillation."
---Jasmina Brooks President of Johnson & Johnson ElectrophysiologyLast year, Johnson & Johnson inFirst announced at EHRA 2024Dual-EnergyTHERMOCOOL SMARTTOUCH Clinical Research Data of SF Ablation Catheter (SmartfIRE). The study showsDual-EnergyTHERMOCOOL SMARTTOUCHSF AblationCatheter Implementation100% acute success rate and96.8% of veins achieved first-pass isolation.SmartfIRE Study is alsoDual-energyTHERMOCOOL SMARTTOUCHSF AblationCatheter Receives CE Approval Key.
BesidesSmaIn addition to the rtfIRE study, the SmartPulse clinical study is being conducted in the United States, and the PulseSmart clinical study is being carried out in Australia and Canada."Through the same catheterThe ability to deliver both RF and PFA energy simplifies the workflow of ablation procedures and enables personalized treatment.In addition, the integration of the dual-energy THERMOCOOL SMARTTOUCH SF ablation catheter with CARTO 3 enables real-time catheter visualization and contact force measurement feedback, which are crucial factors for the formation of durable lesions.”---Dhanunjaya Lakkireddy Kansas City Heart Rhythm Institute"SmartPulse and PulseSmart studies are part of a series of PFA clinical trials and various research programs being conducted by Johnson & Johnson Medical Technologies. These trials and programs aim to generate the necessary evidence to guide informed treatment decisions, optimize clinical use, and ultimately improve the outcomes of atrial fibrillation treatments."”
---Jennifer Currin Johnson & JohnsonVice President of Academic Affairs
The dual-energy THERMOCOOL SMARTTOUCH SF ablation catheter is the second product to receive CE approval.Ablation catheters. The first one is Medtronic's Sphere-9 (this product also received FDA approval last year and was previously considered the most promising dual-energy ablation catheter overseas).THERMOCOOL SMARTTOUCH SF Ablation Catheter is one of the most widely used radiofrequency ablation catheters in the market, and clinicians are very familiar with it. This time,THERMOCOOL SMARTTOUCH SF Ablation Catheter Upgraded toDual-Energy THERMOCOOL SMARTTOThe UCH SF ablation catheter, combined with the CARTO 3 three-dimensional mapping function, will enable doctors to quickly get started.Dual-Energy THERMOCOOL SMARTTOUCH SF Ablation Catheter, Reducing Doctors' Learning Costs.
The launch of the dual-energy THERMOCOOL SMARTTOUCH SF ablation catheter has added a new PFA weapon to Johnson & Johnson's arsenal, helping to offset some disadvantages in its competition against Medtronic and Boston Scientific in the electrophysiology field. Johnson & Johnson will still need to provide more advanced "weapons." The "PFA war" is beginning to intensify, and having more differentiated "weapons" will be key to success on the "battlefield."
THERMOCOL SMARTTOUCH SFIt is a porous-tip saline-infusion ablation catheter., which combines Thermocool SmartTouch technology with the SF catheter's porousPerfusion TechnologyCombined. This catheter combines contact force sensing with advanced porous-tip ablation technology and enhances maneuverability and torque for superior control.THERMOCOL SMARTTOUCH SFThe 56 saline-infused micropores evenly distributed at the distal end of the ablation catheter create a layer of water film at the catheter tip, achieving uniform cooling. This reduces the temperature at the catheter tip during the radiofrequency ablation process, ensuring efficient delivery of radiofrequency energy while minimizing the formation of eschar and small thrombi.
THERMOCOL SMARTTOUCH SFCompared with THERMOCOL SMARTTOUCH, uniform cooling is achieved at half the flow rate.Compared with the SMART-AF studyIn comparison, the distribution of operation time and fluoroscopy time decreased by 19% and 55%, respectively.
THERMOCOL SMARTTOUCH SFIn addition to the uniform cooling advantage, it also inherits the Thermocool SmartTouch contact force sensing technology.- Allows active measurement of stable contact force and catheter tip direction
Using precision springs to respond to contact force for consistent motion
Send accurate position reference signals through position sensors and transmitter coils
Promote Consistent Lesion Formation
- Improved Outcomes Through More Stable Catheter-Tissue Contact Force
Biosense Webster, a professional medical device company under Johnson & Johnson, is dedicated to researching and developing electrophysiological interventional diagnosis and treatment products, providing comprehensive solutions for arrhythmia diseases to physicians and patients. Biosense has established itself as a world leader in 3D mapping systems and software through its excellent and innovative technology.It is also the inventor of the world's first curved catheter.
